HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diclofenac potassium restores objective and subjective measures of sleep quality in women with primary dysmenorrhea.

AbstractSTUDY OBJECTIVES:
Primary dysmenorrhea is a common gynecological disorder that disrupts daytime functioning and nighttime sleep quality. We determined the effectiveness of diclofenac potassium, compared to placebo, in alleviating nighttime pain and restoring sleep architecture in women with primary dysmenorrhea.
DESIGN:
Randomized, double-blind, crossover study.
SETTING:
Sleep laboratory.
PARTICIPANTS:
Ten healthy women (21 +/- 1 years) with a history of primary dysmenorrhea.
INTERVENTIONS:
Placebo or diclofenac potassium (150 mg per day) for menstrual pain.
MEASUREMENTS AND RESULTS:
We assessed objective measures of sleep (polysomnography) and subjective measures of sleep quality, mood, and intensity of menstrual pain. Compared to a pain-free phase of the menstrual cycle (mid-follicular), women receiving placebo for their menstrual pain had a poorer mood (P < 0.01), decreased sleep efficiency (P < 0.05), less REM sleep (P < 0.05), more stage 1 sleep (P < 0.01), and more sleep stage changes per hour of sleep during the night. Administration of diclofenac potassium compared to placebo not only attenuated the women's menstrual pain (P < 0.05), but also increased sleep efficiency (P < 0.05) and percentage of REM sleep (P < 0.01), decreased percentage of stage 1 sleep (P < 0.05) and number of sleep stage changes per hour of sleep (P < 0.05), and improved subjective ratings of sleep quality and morning vigilance (P < 0.05).
CONCLUSION:
Diclofenac potassium effectively attenuates nighttime dysmenorrheic pain and restores subjective and objective measures of sleep quality to values recorded in a pain-free phase of the menstrual cycle.
AuthorsStella Iacovides, Ingrid Avidon, Alison Bentley, Fiona C Baker
JournalSleep (Sleep) Vol. 32 Issue 8 Pg. 1019-26 (Aug 2009) ISSN: 0161-8105 [Print] United States
PMID19725253 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Diclofenac
Topics
  • Affect (drug effects)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Cross-Over Studies
  • Diclofenac (therapeutic use)
  • Double-Blind Method
  • Dysmenorrhea (drug therapy, psychology)
  • Female
  • Humans
  • Pain Measurement
  • Polysomnography (drug effects)
  • Sleep Initiation and Maintenance Disorders (drug therapy)
  • Sleep Stages (drug effects)
  • Wakefulness (drug effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: